Lilly v. Astrazeneca Pharmaceuticals LP
Lilly v. Astrazeneca Pharmaceuticals LP is a federal product liability lawsuit filed on 01/30/2019 in the District Court, D. New Jersey. The case was terminated on 09/24/2021.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Claire C. Cecchi · 12,702 cases in index
- Docket number
- 2:19-cv-02626
- Nature of suit
- 367 Health care / pharm
Injury from a drug, medical device, or health-care product — often grouped into mass-tort litigation. - Jurisdiction
- Diversity of citizenship
- Date filed
- 01/30/2019
- Date terminated
- 09/24/2021
51,458 Product Liability cases in this court are indexed here.
Parties
- plaintiff · Lilly · 325 cases
- defendant · Astrazeneca Pharmaceuticals LP · 8379 cases
Part of a Larger Litigation Pattern
This is one of 8,380 Product Liability cases in our index naming ASTRAZENECA PHARMACEUTICALS LP — a possible mass-tort or coordinated-litigation cluster.
About Product Liability Lawsuits
Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
Frequently Asked Questions
What is Lilly v. Astrazeneca Pharmaceuticals LP?
Lilly v. Astrazeneca Pharmaceuticals LP is a federal product liability lawsuit filed on 01/30/2019 in the District Court, D. New Jersey. The case was terminated on 09/24/2021. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
What type of case is this?
It is classified as “Product Liability” under the federal nature-of-suit system. Product liability lawsuits claim that a defective or dangerous product caused injury or harm. These often target manufacturers of drugs, medical devices, vehicles, or consumer goods, and are frequently grouped into mass-tort or multidistrict litigation when many people are affected by the same product.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 2:19-cv-02626.
When was the case filed?
Lilly v. Astrazeneca Pharmaceuticals LP was filed on 01/30/2019. It was terminated on 09/24/2021.
Other Cases Involving These Parties
Related Product Liability Cases
Source: public U.S. federal court record (docket 18384248).